The performance of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key regions has introduced considerable uncertainty . Investors are now facing the consequences of lower-cost alternat